479 related articles for article (PubMed ID: 25948873)
1. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.
Rabant M; Amrouche L; Lebreton X; Aulagnon F; Benon A; Sauvaget V; Bonifay R; Morin L; Scemla A; Delville M; Martinez F; Timsit MO; Duong Van Huyen JP; Legendre C; Terzi F; Anglicheau D
J Am Soc Nephrol; 2015 Nov; 26(11):2840-51. PubMed ID: 25948873
[TBL] [Abstract][Full Text] [Related]
2. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation.
Blydt-Hansen TD; Gibson IW; Gao A; Dufault B; Ho J
Transplantation; 2015 Apr; 99(4):797-804. PubMed ID: 25222013
[TBL] [Abstract][Full Text] [Related]
3. Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.
Hirt-Minkowski P; Rush DN; Gao A; Hopfer H; Wiebe C; Nickerson PW; Schaub S; Ho J
Transplantation; 2016 Sep; 100(9):1988-96. PubMed ID: 27548845
[TBL] [Abstract][Full Text] [Related]
4. Urinary C-X-C Motif Chemokine 10 Is Related to Acute Graft Lesions Secondary to T Cell- and Antibody-Mediated Damage.
Arnau A; Benito-Hernández A; Ramos-Barrón MA; García-Unzueta MT; Gómez-Román JJ; Gómez-Ortega JM; López-Hoyos M; San Segundo D; Ruiz JC; Rodrigo E
Ann Transplant; 2021 Mar; 26():e929491. PubMed ID: 33686050
[TBL] [Abstract][Full Text] [Related]
5. Urinary C‑X‑C motif chemokine 13 is a noninvasive biomarker of antibody‑mediated renal allograft rejection.
Chen D; Zhang J; Peng W; Weng C; Chen J
Mol Med Rep; 2018 Aug; 18(2):2399-2406. PubMed ID: 29956754
[TBL] [Abstract][Full Text] [Related]
6. Elevated Urinary Matrix Metalloproteinase-7 Detects Underlying Renal Allograft Inflammation and Injury.
Ho J; Rush DN; Krokhin O; Antonovici M; Gao A; Bestland J; Wiebe C; Hiebert B; Rigatto C; Gibson IW; Wilkins JA; Nickerson PW
Transplantation; 2016 Mar; 100(3):648-54. PubMed ID: 26906940
[TBL] [Abstract][Full Text] [Related]
7. Early Low Urinary CXCL9 and CXCL10 Might Predict Immunological Quiescence in Clinically and Histologically Stable Kidney Recipients.
Rabant M; Amrouche L; Morin L; Bonifay R; Lebreton X; Aouni L; Benon A; Sauvaget V; Le Vaillant L; Aulagnon F; Sberro R; Snanoudj R; Mejean A; Legendre C; Terzi F; Anglicheau D
Am J Transplant; 2016 Jun; 16(6):1868-81. PubMed ID: 26694099
[TBL] [Abstract][Full Text] [Related]
8. Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection.
Jackson JA; Kim EJ; Begley B; Cheeseman J; Harden T; Perez SD; Thomas S; Warshaw B; Kirk AD
Am J Transplant; 2011 Oct; 11(10):2228-34. PubMed ID: 21812928
[TBL] [Abstract][Full Text] [Related]
9. Evolution of renal function and urinary biomarker indicators of inflammation on serial kidney biopsies in pediatric kidney transplant recipients with and without rejection.
Mincham CM; Gibson IW; Sharma A; Wiebe C; Mandal R; Rush D; Nickerson P; Ho J; Wishart DS; Blydt-Hansen TD
Pediatr Transplant; 2018 Aug; 22(5):e13202. PubMed ID: 29696778
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft Recipients.
Mühlbacher J; Doberer K; Kozakowski N; Regele H; Camovic S; Haindl S; Bond G; Haslacher H; Eskandary F; Reeve J; Böhmig GA; Wahrmann M
Front Med (Lausanne); 2020; 7():114. PubMed ID: 32328494
[No Abstract] [Full Text] [Related]
11. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
Front Immunol; 2020; 11():342. PubMed ID: 32184785
[TBL] [Abstract][Full Text] [Related]
13. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection.
Tsuji T; Yanai M; Itami H; Ishii Y; Akimoto M; Fukuzawa N; Harada H; Fukasawa Y
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():26-30. PubMed ID: 26031582
[TBL] [Abstract][Full Text] [Related]
14. Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation.
Millán O; Budde K; Sommerer C; Aliart I; Rissling O; Bardaji B; Matz M; Zeier M; Silva I; Guirado L; Brunet M
Br J Clin Pharmacol; 2017 Dec; 83(12):2636-2650. PubMed ID: 28880456
[TBL] [Abstract][Full Text] [Related]
15. Optimizing the approach to monitoring allograft inflammation using serial urinary CXCL10/creatinine testing in pediatric kidney transplant recipients.
Barrett-Chan E; Wang L; Bone J; Thachil A; Vytlingam K; Blydt-Hansen T
Pediatr Transplant; 2024 May; 28(3):e14718. PubMed ID: 38553815
[TBL] [Abstract][Full Text] [Related]
16. Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.
Crespo E; Roedder S; Sigdel T; Hsieh SC; Luque S; Cruzado JM; Tran TQ; Grinyó JM; Sarwal MM; Bestard O
Transplantation; 2017 Jun; 101(6):1400-1409. PubMed ID: 27362314
[TBL] [Abstract][Full Text] [Related]
17. The association of urinary interferon-gamma inducible protein-10 (IP10/CXCL10) levels with kidney allograft rejection.
Raza A; Firasat S; Khaliq S; Aziz T; Mubarak M; Naqvi SA; Mehdi SQ; Rizvi SA; Abid A
Inflamm Res; 2017 May; 66(5):425-432. PubMed ID: 28246678
[TBL] [Abstract][Full Text] [Related]
18. Long-term kidney allograft survival in patients with transplant glomerulitis.
Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.
Karason K; Jernås M; Hägg DA; Svensson PA
BMC Cardiovasc Disord; 2006 Jun; 6():29. PubMed ID: 16780603
[TBL] [Abstract][Full Text] [Related]
20. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts.
Suthanthiran M; Schwartz JE; Ding R; Abecassis M; Dadhania D; Samstein B; Knechtle SJ; Friedewald J; Becker YT; Sharma VK; Williams NM; Chang CS; Hoang C; Muthukumar T; August P; Keslar KS; Fairchild RL; Hricik DE; Heeger PS; Han L; Liu J; Riggs M; Ikle DN; Bridges ND; Shaked A;
N Engl J Med; 2013 Jul; 369(1):20-31. PubMed ID: 23822777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
